Search

Author/Creator Bokorova, R.

1. 42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA. (April 2015)

Authors:
Fuchs, O.; Polak, J.; Bokorova, R.; Vostry, M.; Kostecka, A.; Hajkova, H.; Neuwirtova, R.; Siskova, M.; Cermak, J.; Sponerova, D.; Lauermannova, M.; Soukupova, J.; Cervinek, L.; Brezinova, J.; Michalova, K.; Jonasova, A.
Journal:
Leukemia research
Issue:
Volume 39(2015:Apr.) Supplement 1
Page Start:
S18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients. (April 2017)

Authors:
Fuchs, O.; Polak, J.; Bokorova, R.; Kostecka, A.; Vostry, M.; Neuwirtova, R.; Siskova, M.; Stopka, T.; Lauermannova, M.; Maaloufova, J. Soukupova; Salek, C.; Mikulenkova, D.; Cermak, J.; Brezinova, J.; Zemanova, Z.; Michalova, K.; Jonasova, A.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels. (April 2017)

Authors:
Fuchs, O.; Polak, J.; Bokorova, R.; Kostecka, A.; Vostry, M.; Jonasova, A.; Myslivcova, D.; Siskova, M.; Stopka, T.; Lauermannova, M.; Salek, C.; Maaloufova, J. Soukupova; Mikulenkova, D.; Cermak, J.; Brezinova, J.; Zemanova, Z.; Michalova, K.; Neuwirtova, R.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search